Institutional Ownership
Anika Therapeutics Inc
CUSIP 035255108COMANIKQ1 2026
13D / 13G Filings
54
Schedule 13D/13G on record
Beneficial Filers
13
Distinct reporting persons
Largest Stake
17.3%
Max % of class reported
Institutional Holders
125
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
54 filings · latest Jan 27, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Jan 27, 2026 | Caligan Partners LP | 13D/A | 9.9% | — | SEC |
| 2 | Jan 8, 2026 | Trigran Investments, Inc. | 13G/A | 11.0% | 168.4K | SEC |
| 3 | Nov 21, 2025 | Caligan Partners LP | 13D/A | 9.9% | — | SEC |
| 4 | Nov 7, 2025 | Trigran Investments, Inc. | 13G/A | 11.2% | 1.62M | SEC |
| 5 | Oct 17, 2025 | Blackrock Portfolio Management LLC | 13G | 5.5% | 793.4K | SEC |
| 6 | Apr 17, 2025 | Blackrock, Inc. | 13G/A | 6.8% | 963.1K | SEC |
| 7 | Feb 5, 2025 | Blackrock, Inc. | 13G/A | 10.6% | 1.56M | SEC |
| 8 | Jan 23, 2025 | Dimensional Fund Advisors LP | 13G/A | 4.5% | 657.4K | SEC |
| 9 | Nov 8, 2024 | Blackrock, Inc. | 13G/A | 11.9% | 1.76M | SEC |
| 10 | Oct 23, 2024 | Blackrock, Inc. | 13G/A | 11.9% | 1.76M | SEC |
44 more beneficial-ownership filings on Premium
See the full Schedule 13D/13G history for Anika Therapeutics Inc.
Unlock full historyTop Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Blackrock, Inc. | 1.59M | $23.13M |
| 2 | Caligan Partners LP | 1.44M | $20.81M |
| 3 | Morgan Stanley | 872.1K | $12.64M |
| 4 | Boothbay Fund Management, LLC | 529.5K | $7.68M |
| 5 | Renaissance Technologies LLC | 502.2K | $7.28M |
| 6 | Dimensional Fund Advisors LP | 458.8K | $6.65M |
| 7 | Capital Management Corp /Va | 447.7K | $6.49M |
| 8 | Deutsche Bank AG\ | 353.2K | $5.12M |
| 9 | State Street Corp | 346.1K | $5.02M |
| 10 | Geode Capital Management, LLC | 330.1K | $4.79M |